Loss of multimerin-2 and EMILIN-2 expression in gastric cancer associate with altered angiogenesis

Eva Andreuzzi, Alessandra Capuano, Rosanna Pellicani, Evelina Poletto, Roberto Doliana, Stefania Maiero, Mara Fornasarig, Raffaella Magris, Alfonso Colombatti, Renato Cannizzaro, Paola Spessotto, Maurizio Mongiat

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gastric cancer is a deadly tumor and a relatively common disease worldwide. Surgical resection and chemotherapy are the main clinical options to treat this type of disease, however the median overall survival rate is limited to one year. Thus, the development of new therapies is a highly necessary clinical need. Angiogenesis is a promising target for this tumor type, however clinical trials with the use of anti-angiogenic drugs have so far not met expectations. Therefore, it is important to better characterize the expression of molecules whose expression levels may impact on the efficacy of the treatments. In this study the characteristics of the gastric tumor associated blood vessels were first assessed by endomicroscopy. Next, we analyzed the expression of Multimerin-2, EMILIN-2 and EMILIN-1, three molecules of the EMI Domain ENdowed (EDEN) protein family. These molecules play important functions in the tumor microenvironment, affecting cancer progression both directly and indirectly impinging on angiogenesis and lymphangiogenesis. All the molecules were highly expressed in the normal mucosa whereas in a number of patients their expression was altered. We consider that better characterizing the gastric tumor microenvironment and the quality of the vasculature may achieve effective patient tailored therapies.

Original languageEnglish
Article number3983
JournalInternational Journal of Molecular Sciences
Volume19
Issue number12
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

angiogenesis
Stomach Neoplasms
Tumors
Tumor Microenvironment
tumors
cancer
Stomach
Molecules
Vascular Tissue Neoplasms
Lymphangiogenesis
Neoplasms
Angiogenesis Inhibitors
molecules
therapy
Mucous Membrane
Survival Rate
Clinical Trials
Chemotherapy
blood vessels
Blood vessels

Keywords

  • Angiogenesis
  • Endomicroscopy
  • Extracellular matrix
  • Gastric cancer
  • Lymphangiogenesis
  • Tumor microenvironment

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Loss of multimerin-2 and EMILIN-2 expression in gastric cancer associate with altered angiogenesis. / Andreuzzi, Eva; Capuano, Alessandra; Pellicani, Rosanna; Poletto, Evelina; Doliana, Roberto; Maiero, Stefania; Fornasarig, Mara; Magris, Raffaella; Colombatti, Alfonso; Cannizzaro, Renato; Spessotto, Paola; Mongiat, Maurizio.

In: International Journal of Molecular Sciences, Vol. 19, No. 12, 3983, 01.12.2018.

Research output: Contribution to journalArticle

@article{006bad1d24934a019d487d4cfb0d95fb,
title = "Loss of multimerin-2 and EMILIN-2 expression in gastric cancer associate with altered angiogenesis",
abstract = "Gastric cancer is a deadly tumor and a relatively common disease worldwide. Surgical resection and chemotherapy are the main clinical options to treat this type of disease, however the median overall survival rate is limited to one year. Thus, the development of new therapies is a highly necessary clinical need. Angiogenesis is a promising target for this tumor type, however clinical trials with the use of anti-angiogenic drugs have so far not met expectations. Therefore, it is important to better characterize the expression of molecules whose expression levels may impact on the efficacy of the treatments. In this study the characteristics of the gastric tumor associated blood vessels were first assessed by endomicroscopy. Next, we analyzed the expression of Multimerin-2, EMILIN-2 and EMILIN-1, three molecules of the EMI Domain ENdowed (EDEN) protein family. These molecules play important functions in the tumor microenvironment, affecting cancer progression both directly and indirectly impinging on angiogenesis and lymphangiogenesis. All the molecules were highly expressed in the normal mucosa whereas in a number of patients their expression was altered. We consider that better characterizing the gastric tumor microenvironment and the quality of the vasculature may achieve effective patient tailored therapies.",
keywords = "Angiogenesis, Endomicroscopy, Extracellular matrix, Gastric cancer, Lymphangiogenesis, Tumor microenvironment",
author = "Eva Andreuzzi and Alessandra Capuano and Rosanna Pellicani and Evelina Poletto and Roberto Doliana and Stefania Maiero and Mara Fornasarig and Raffaella Magris and Alfonso Colombatti and Renato Cannizzaro and Paola Spessotto and Maurizio Mongiat",
year = "2018",
month = "12",
day = "1",
doi = "10.3390/ijms19123983",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "12",

}

TY - JOUR

T1 - Loss of multimerin-2 and EMILIN-2 expression in gastric cancer associate with altered angiogenesis

AU - Andreuzzi, Eva

AU - Capuano, Alessandra

AU - Pellicani, Rosanna

AU - Poletto, Evelina

AU - Doliana, Roberto

AU - Maiero, Stefania

AU - Fornasarig, Mara

AU - Magris, Raffaella

AU - Colombatti, Alfonso

AU - Cannizzaro, Renato

AU - Spessotto, Paola

AU - Mongiat, Maurizio

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Gastric cancer is a deadly tumor and a relatively common disease worldwide. Surgical resection and chemotherapy are the main clinical options to treat this type of disease, however the median overall survival rate is limited to one year. Thus, the development of new therapies is a highly necessary clinical need. Angiogenesis is a promising target for this tumor type, however clinical trials with the use of anti-angiogenic drugs have so far not met expectations. Therefore, it is important to better characterize the expression of molecules whose expression levels may impact on the efficacy of the treatments. In this study the characteristics of the gastric tumor associated blood vessels were first assessed by endomicroscopy. Next, we analyzed the expression of Multimerin-2, EMILIN-2 and EMILIN-1, three molecules of the EMI Domain ENdowed (EDEN) protein family. These molecules play important functions in the tumor microenvironment, affecting cancer progression both directly and indirectly impinging on angiogenesis and lymphangiogenesis. All the molecules were highly expressed in the normal mucosa whereas in a number of patients their expression was altered. We consider that better characterizing the gastric tumor microenvironment and the quality of the vasculature may achieve effective patient tailored therapies.

AB - Gastric cancer is a deadly tumor and a relatively common disease worldwide. Surgical resection and chemotherapy are the main clinical options to treat this type of disease, however the median overall survival rate is limited to one year. Thus, the development of new therapies is a highly necessary clinical need. Angiogenesis is a promising target for this tumor type, however clinical trials with the use of anti-angiogenic drugs have so far not met expectations. Therefore, it is important to better characterize the expression of molecules whose expression levels may impact on the efficacy of the treatments. In this study the characteristics of the gastric tumor associated blood vessels were first assessed by endomicroscopy. Next, we analyzed the expression of Multimerin-2, EMILIN-2 and EMILIN-1, three molecules of the EMI Domain ENdowed (EDEN) protein family. These molecules play important functions in the tumor microenvironment, affecting cancer progression both directly and indirectly impinging on angiogenesis and lymphangiogenesis. All the molecules were highly expressed in the normal mucosa whereas in a number of patients their expression was altered. We consider that better characterizing the gastric tumor microenvironment and the quality of the vasculature may achieve effective patient tailored therapies.

KW - Angiogenesis

KW - Endomicroscopy

KW - Extracellular matrix

KW - Gastric cancer

KW - Lymphangiogenesis

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85058271031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058271031&partnerID=8YFLogxK

U2 - 10.3390/ijms19123983

DO - 10.3390/ijms19123983

M3 - Article

C2 - 30544909

AN - SCOPUS:85058271031

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 3983

ER -